Writing away the pain: Text-Based therapy tested for suicidal youth
NCT ID NCT07479823
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a guided expressive writing program can reduce suicidal thoughts in 160 adolescents and young adults aged 13 to 24. Participants will complete short writing sessions several times a week for four weeks, focusing on emotions and personal experiences. Researchers will compare changes in suicidal thoughts, depression, and impulsivity between those who do the writing program plus usual care and those who receive usual care alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Structured expressive writing program
What this could lead to
If it works, this could offer a simple, low-cost tool to help young people manage suicidal thoughts and emotional distress.
What could go wrong
This is an early-stage trial with a behavioral intervention, so results may be modest or not generalize. The writing program is added to usual care, not a replacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••